突破！济医附院首次获批山东省重点研发计划项目

Core Viewpoint - The Shandong Provincial Department of Science and Technology has approved the "Stem Cell sEV for Regenerative Repair of Key Organs and Clinical Industrial Transformation" project from Jinan Medical University Affiliated Hospital, marking a significant breakthrough in the hospital's pharmaceutical product development and recognition at the provincial level [1][3]. Group 1: Project Approval and Significance - The project is part of the Shandong Provincial Key R&D Program (Competitive Innovation Platform), aimed at gathering innovative resources and tackling key technologies [3]. - The approval signifies Jinan Medical University Affiliated Hospital's strong development momentum in cell therapy research and clinical industrial transformation [3]. Group 2: Project Focus and Goals - The project, led by Professor Zhang Bin, will focus on key scientific issues and industrial bottlenecks related to stem cell extracellular vesicles (sEV) in tissue regeneration and repair [3]. - The aim is to analyze the secretion regulation mechanisms of sEV, optimize engineering modification technologies, and establish standardized production systems, creating a complete industrial chain from basic research to clinical transformation [3]. Group 3: Future Development and Impact - The establishment and operation of this platform will significantly enhance innovation in the field of stem cells and regenerative medicine, improving the hospital's core competitiveness in biotherapy technology and product development [4]. - The hospital plans to leverage this opportunity to advance platform construction, focus on core technology breakthroughs, deepen industry-academia-research cooperation, and accelerate the transformation of research outcomes [4].